Drug Shortage Report for PMS-CYTARABINE

Last updated on 2022-02-16 History
Report ID 146890
Drug Identification Number 02406772
Brand name PMS-CYTARABINE
Common or Proper name CYTARABINE
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) CYTARABINE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRATHECAL SUBCUTANEOUS INTRAVENOUS INTRATHECAL
Packaging size 2000mg/20mL
ATC code L01BC
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-01-04
Actual start date
Estimated end date 2022-02-25
Actual end date 2022-02-15
Shortage status Resolved
Updated date 2022-02-16
Company comments Limited supply. Anticipated BO from January 4, 2022 to February 25, 2022
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2022-02-16 French Compare
v15 2022-02-16 English Compare
v14 2022-01-05 English Compare
v13 2021-12-01 French Compare
v12 2021-12-01 English Compare
v11 2021-11-23 French Compare
v10 2021-11-23 English Compare
v9 2021-11-08 French Compare
v8 2021-11-08 English Compare
v7 2021-11-05 French Compare
v6 2021-11-05 English Compare
v5 2021-11-05 English Compare
v4 2021-10-28 French Compare
v3 2021-10-28 English Compare
v2 2021-10-07 French Compare
v1 2021-10-07 English Compare

Showing 1 to 16 of 16